-
hcup-us.ahrq.gov/reports/methods/2008_04.pdf
January 01, 2008 - 1.10 1.07 0.98 1.04
41: Cancer; other and unspecified primary 1.00 1.00 0.97 1.04 1.02 0.99 0.95
42: Secondary … Essential hypertension 1.06 1.05 1.09 1.05 1.08 1.03 1.08
99: Hypertension with complications and
secondary
-
hcup-us.ahrq.gov/reports/methods/2012_04.pdf
January 01, 2012 - are considered for the same principal diagnosis CCS, for the
same diagnosis CCS as a principal or secondary … Use of Secondary Procedure Days in the AHRQ Quality Indicators, Version 3.1
Table 5.
-
hcup-us.ahrq.gov/reports/CountyHighOpioidHospitalRates.pdf
December 01, 2020 - county population rate of opioid-related hospitalizations
identified using any-listed (principal or secondary … Finally, most hospitalizations in our sample
(83.7%) were identified by a secondary opioid-related diagnosis
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/lysosomal-storage-diseases-therapies_disposition-comments.pdf
January 01, 2014 - storage disorders (LSD)
comprise a group of unique monogenic autosomal or
X-linked diseases that occur secondary … The text was revised to read as follows: “Most
LSD patients present with symptoms secondary to
existing … Secondary endpoints of the phase II/III clinical trial are not
included
Please populate the columns … ERT does not cross the
blood-brain barrier, and therefore, has no cognitive benefits,
except for secondary … cognitive function” perhaps could have been the result
of fatigue, or a decrement in physical function
secondary
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol3/Advances-Hurley_55.pdf
March 07, 2008 - Rapids is a northeastern Iowa community with a population of approximately 150,000,
and a primary and secondary
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/blood-clots-hip-knee-surgery_disposition-comments.pdf
March 01, 2012 - Relative to effectiveness of each of the three
prophylaxis regimens, secondary observations include; … Studies
Efficacy Outcomes
Primary Efficacy Outcome
● DVT, non-fatal PE, all-cause mortality
Main Secondary … They reported on
primary and secondary diagnosis and did not analyze
orthopedic surgery specifically … The focus of this CER was not secondary
prevention therefore outcomes such as recurrent VTE were not … DVTs occur at a higher rate than PEs as primary and
secondary diagnoses.
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs023875-kazemi-final-report-2018.pdf
January 01, 2018 - Alcohol use
among students also results in secondary effects on the campus environment7(30). … Secondary prevention with college
drinkers: Evaluation of an alcohol skills training program.
-
effectivehealthcare.ahrq.gov/sites/default/files/implementation-package-unhealthy-alcohol-use-final.pdf
September 01, 2018 - The Provider Guide for Addressing Unhealthy Alcohol Use
Secondary References:
4. … SECONDARY REFERENCES:
3. Cole, Stephen.
-
www.ahrq.gov/patient-safety/settings/long-term-care/resource/ontime/prevhosp/ereportguide.html
September 01, 2017 - Discharge diagnoses from hospital (principal diagnosis and secondary diagnoses). … Discharge diagnoses from hospital (principal diagnosis and secondary diagnoses).
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-failure-natriuretic-peptide_disposition-comments.pdf
November 20, 2013 - Four articles were secondary analyses of data initially
collected in RCTs; however, the secondary analyses
-
www.ahrq.gov/hai/cusp/toolkit/content-calls/briefing.html
April 01, 2013 - Is there a patient who requires my immediate attention secondary to acuity? … consistent care when our step-down unit was run by all nurse practitioners and the residents really played a secondary
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/head-neck-cancer-update_research-protocol.pdf
February 04, 2014 - subpopulations; and, finally, 4) whether there is more variation in patient outcomes with
any modality secondary … important harms or for certain
key questions when it is deemed at less risk for study limitations secondary
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs022670-patel-final-report-2019.pdf
January 01, 2019 - This will require the translation of easily available secondary data (e.g., EHR data logs, sensor-based … • Collecting secondary data from audit trails (unobtrusive and automated)
• Building support for data
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2021_Core.PDF
January 01, 2021 - POORLY DIFFERENT NEOPLASTIC DIAG WITHOUT
CC/MCC
197 0.00%
846: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS WITH MCC 3,234 0.05%
847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH … CC 14,465 0.22%
848: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT
CC/MCC
457
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2020_Core_V2.PDF
January 01, 2020 - Distribution for DRG_NOPOA
DRG_NoPOA Frequency
Percent
of Total
846: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS WITH MCC 3,138 0.05%
847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH … CC 14,661 0.23%
848: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT
CC/MCC
543
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2022_Core.PDF
January 01, 2022 - POORLY DIFFERENT NEOPLASTIC DIAG WITHOUT
CC/MCC
203 0.00%
846: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS WITH MCC 3,542 0.05%
847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH … CC 13,710 0.21%
848: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT
CC/MCC
465
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2017_Core_Weighted.PDF
January 01, 2017 - MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC 1,560 0.00%
846: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS W MCC 18,230 0.05%
847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 86,405 … 0.24%
848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 4,195 0.01%
849: RADIOTHERAPY
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2019_Core_V2.PDF
January 01, 2019 - MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC 288 0.00%
846: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS W MCC 3,200 0.05%
847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 16,680 … 0.24%
848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 732 0.01%
849: RADIOTHERAPY
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2016_Core_Weighted.PDF
January 01, 2016 - MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC 1,730 0.00%
846: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS W MCC 16,285 0.05%
847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 87,820 … 0.25%
848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 5,030 0.01%
849: RADIOTHERAPY
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/tobacco-use-in-adults-and-pregnant-women-counseling-and-interventions
January 19, 2021 - E-cigarettes versus NRT for smoking reduction or cessation in people with mental illness: secondary analysis … secondary analyses of a randomised controlled trial. … Across all 7 trials, there was mixed evidence on secondary process outcomes such as documentation of